Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience

Table 1

Baseline characteristics of patients and biochemical analyses before and after total PTX with forearm AT.

	Total population
	Male n (%)	14 (36.8)
Age (year)	56 ± 13
Dialysis vintage (months)	80 ± 44
Pre-iPTH (pg/ml)	1621 ± 532
Post-iPTH (pg/ml)	57 ± 70
<10	8 (21.1)
10–70	26 (68.4)
>70	4 (10.5)
6 months iPTH (pg/ml)	55 ± 66
<10	1 (2.6)
10–70	35 (92.1)
>70	2 (5.3)
12 months iPTH (pg/ml)	55 ± 70
24 months iPTH (pg/ml)	57 ± 72
36 months iPTH (pg/ml)	58 ± 76
60 months iPTH (pg/ml)	61 ± 93
Follow-up time after PTX + AT (months)	109 ± 19
Long-term hypoparathyroidism	1 (2.6)
Persistent hyperparathyroidism	2 (5.3)
Recurrence hyperparathyroidism	2 (5.3)
Autograftectomy	3 (7.9)

Data are show as mean ± standard deviation or number (%). Abbreviations: PTX: total parathyroidectomy; AT: autotransplantation; Pre-iPTH: preoperative intact-parathyroid hormone; Post-iPTH: postoperative intact-parathyroid hormone; 6, 12, 24, 36, and 60 months iPTH: intact-parathyroid hormone measurement at 6, 12, 24, 36, and 60 months, respectively, after PTX + AT.